Success in the Life Sciences industry depends on getting new products to market quickly and cost effectively. Organizations must master clinical development and regulatory submission processes to recoup their R&D investments over the relatively short lifespan of patents. They must also build strong relationships with the provider community.

EMC recommends that companies examine their end-to-end development processes to identify process bottlenecks, eliminate waste, and drive down cycle times. Moving new products through development quickly requires a new approach to process optimization and execution.

A value-stream approach to analyzing clinical processes enables you to streamline operations. The strategic use of information and information technology reduces cycle times and improves the flow of communication with investigators and regulatory bodies. Leveraging technology and information at critical steps in the process improves productivity and speeds up time-to-market.

Increasingly sophisticated financial innovation has led to greater complexity of products and services in the financial services marketplace. It has also shortened product lifecycles. Many new products fail to meet revenue expectations and others succeed at the expense of older product revenue streams.

EMC Consulting recommends that firms segment the market, assess client needs, and carefully screen product and service concepts for projected market-share penetration. You should also consider the likelihood of cannibalizing existing offerings.

You may need to transform operating processes or design new service delivery platforms to respond quickly to new market opportunities. When bringing new offerings to market, follow a well developed launch process to increase the chance of success. Tailor the launch process to the needs and expectations of the business.